We are live on !
Find out more
Ulys LLC Portfolio holdings
AUM
$25.4M
Turnover
0%
1-Year Est. Return
201.03%
This Fund
S&P 500
This Quarter Est. Return
-10.22%
1 Year Est. Return
+201.03%
3 Year Est. Return
-31.51%
5 Year Est. Return
-50.88%
10 Year Est. Return
–
AUM
$51.6M
AUM Growth
-$5.88M
(-10%)
Cap. Flow
$0
Cap. Flow % of AUM
Cap. Flow %
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
–
Reduced
–
Closed
–
Avg Time Held
2.8
years
Top 10 Avg Time Held
2.8
years
Top 20 Avg Time Held
2.8
years
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| 2 | Miscellaneous | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Lexicon Pharmaceuticals
LXRX
$659M
| $51.6M | 100% |
4,321,214
| – | – |
2013 Q2
11 quarters
|
|
2
DELISTED
CERES, INC. COMMON STOCK NEW
CERE
| $1K | ﹤0.01% |
3,891
| – | – |
2013 Q2
11 quarters
|
|
Similar funds
AGEC
Ulys LLC's Q1 2016 Portfolio in Review
As of Q1 2016, Ulys LLC held 2 positions worth $51.6M, down 10% from $57.5M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q1 2016: portfolio turnover was 0%. Ulys LLC opened no new positions and made no exits, leaving the 2-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, down from 100% a quarter earlier, followed by Miscellaneous.
- Ulys LLC's ten largest holdings make up 100% of its $51.6M portfolio in Q1 2016.
- Ulys LLC opened 0 new positions and closed 0 in Q1 2016.
- Ulys LLC's portfolio value fell 10% quarter-over-quarter to $51.6M.
Based on Ulys LLC's 13F filing for Q1 2016, filed 12 May 2016.